Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $18.33M.
ENTERPRISE VALUE (EV)
$18.33M
Pliant Therapeutics, Inc.
Market Cap
$63.78M
Enterprise Value (EV)
$18.33M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $63.78M | $18.33M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
| InterCure Ltd. (INCR)vs › | $63.14M | $105.99M |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.58M | $192.22M |
| RenovoRx, Inc. (RNXT)vs › | $64.88M | $55.66M |
| Gossamer Bio, Inc. (GOSS)vs › | $65.32M | $63.28M |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | $20.00M |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | $43.75M |
| Adicet Bio, Inc. (ACET)vs › | $60.72M | $40.44M |
Market Cap
$63.78M
Total Debt
$0.00
Cash
$45.45M
Enterprise Value
$18.33M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
